Clinical Trials Browser

Unknown × famitinib × Thoracic × Clear all

NCT05042375 2022-11-17

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05005468 2021-08-13

CAMFA-L

Phase 2 Unknown

NSCLC